#biopharmaceuticals (1 Posts)
-
U.S. Congress Fails to Pass Biosecurity Act, WuXi Biologics Resumes Plant Construction The U.S. Congress has failed to pass the Biosecurity Act this year, a bill aimed at countering Chinese biotech firms.
Hot Topics